Sutton Wealth Advisors Inc. Vanda Pharmaceuticals Inc. Transaction History

Sutton Wealth Advisors Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$6.18 - $7.99 $9,362 - $12,104	-1,515 Closed	0 $0
Q3 2022 Nov 07, 2023	BUY	$9.44 - $11.76 $6,853 - $8,537	726 Added 92.02%	1,515 $15 Million
Q2 2022 Nov 07, 2023	BUY	$9.31 - $11.84 $7,345 - $9,341	789 New	789 $8.6 Million
Q1 2022 Nov 07, 2023	SELL	$10.84 - $16.55 $5,810 - $8,870	-536 Closed	0 $0
Q4 2021 Nov 07, 2023	BUY	$15.69 - $21.14 $455 - $613	29 Added 5.72%	536 $8.41 Million
Q3 2021 Nov 07, 2023	BUY	$15.35 - $21.27 $936 - $1,297	61 Added 13.68%	507 $8.69 Million
Q2 2021 Nov 07, 2023	BUY	$15.71 - $21.51 $7,006 - $9,593	446 New	446 $9.59 Million
Q3 2020 Nov 07, 2023	SELL	$9.32 - $12.02 $3,765 - $4,856	-404 Closed	0 $0
Q2 2020 Nov 07, 2023	BUY	$9.66 - $12.02 $3,902 - $4,856	404 New	404 $4.62 Million
Q1 2020 Nov 07, 2023	SELL	$7.5 - $16.8 $5,002 - $11,205	-667 Closed	0 $0
Q4 2019 Nov 07, 2023	SELL	$12.38 - $17.47 $2,835 - $4,000	-229 Reduced 25.56%	667 $10.9 Million
Q2 2019 Nov 06, 2023	SELL	$13.37 - $18.85 $935 - $1,319	-70 Reduced 7.25%	896 $12.6 Million
Q4 2018 Nov 06, 2023	BUY	$18.97 - $31.47 $18,325 - $30,400	966 New	966 $25.2 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.